InvestorsHub Logo
Followers 28
Posts 4417
Boards Moderated 0
Alias Born 11/10/2004

Re: JPL1868 post# 53048

Tuesday, 04/18/2017 10:57:16 AM

Tuesday, April 18, 2017 10:57:16 AM

Post# of 106839
We're past the 60-days because USRM submitted their RMAT application on January 27th, 2017.

On January 27, 2017, U.S. Stem Cell, Inc. applied for the FDA’s new Regenerative Medicine Advanced Therapy (RMAT) designation for the MyoCell™ product as part of the MARVEL trial.


http://us-stemcell.com/en/ceo-blog-exciting-accomplishments-in-april/